Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Takeda
Pfizer
Pfizer
Fusion Pharmaceuticals Inc.
Bristol-Myers Squibb
CureOne
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Auron Healthcare GmbH
Stanford University
Massachusetts General Hospital